NAPPSI and ICT Announce the Winner of the 2005 Primary Prevention Sharps Safety Award
The third annual Primary Prevention Sharps Safety Award is sponsored by the National Alliance for the Primary Prevention of Sharps Injuries (NAPPSI) and ICT, and is awarded to the healthcare facility that most effectively implements a primary prevention program that exemplifies the no needle equals no risk philosophy of NAPPSI. The primary prevention concept prevents sharps injury by implementing a technique or device that eliminates the use of needles and other sharps from the healthcare workplace. This year, the award goes to Florida Hospital of Orlando, the flagship hospital for an integrated healthcare delivery system consisting of seven hospitals and 14 Centra-Care walk-in medical centers. It is part of the Adventist Health System whose mission is to extend the healing ministry of Jesus Christ through a commitment to the physical, mental and spiritual well-being of patients, employees and friends. Congratulations to this outstanding healthcare system.
Primary prevention of sharps injury entails both products and practices. First, lets look at the workplace practices that made Florida Hospital a winner. At Florida Hospital, the sharps safety committee meets quarterly to assess outcomes and extend and implement their exposure control plan throughout the entire system. Pediatrics is included, whenever appropriate, in the committees considerations. In addition, the infection control departments monthly meetings regularly review and analyze all sharps injuries. Florida Hospital recognizes that infection control affects sharps injury prevention; no CVC infection, for example, means no CVC reinsertion, therefore, rigorous emphasis has been placed on handwashing and maximal barrier protection. Florida Hospital also publishes a Clinical News Capsule for all clinicians involved with patient contact. Articles often focus on needlestick safety and infection control principles. Florida Hospital also conducts an annual safety fair, designed to familiarize and instruct all attendees as to current and future sharps safety practices and products.
Perhaps most importantly, Florida Hospital operates its safety programs in accordance with Six Sigma quality and statistical principles. A key element of this program is the early buy-in from top management in the implementation of various safety programs. This enables programs to proceed unencumbered, with top-down support, and full cooperation at all levels. By taking this systems approach, Florida Hospital has created a culture of safety awareness at all levels.
NAPPSI advocates the prudent combination of primary and secondary prevention devices in order to maximize workplace safety (see the Clinician Advisory at www.nappsi.org).
First, some of the primary prevention products in use at Florida Hospital:
- ChloraPrep, 2 percent chlorhexidine gluconate in isopropyl alcohol; this skin antiseptic provides immediate and prolonged antimicrobial action and has received a Category IA recommendation from the Centers for Disease Control and Prevention (CDC).
- StatLock CV Plus, StatLock PICC Plus, and StatLock IV Ultra provide tape-free and suture-free securement for peripheral and central venous catheters. These kinds of products are noted by the CDC as advantageous over suture in preventing catheter-related bloodstream infections and proven in numerous studies to significantly reduce unscheduled catheter restarts.
- Clave and UltraSite luer-activated access valves eliminate the need to use a needle to access an intravenous line, thus allowing for needle-free fluid and medication delivery.
- Arrow Guard Blue CVC; the antimicrobial coating inside and outside of this CVC is proved to prevent catheter-related bloodstream infections. Clinicians should remember that it takes four sharps to normally insert and stabilize a CVC: lidocaine needle, finder needle, scalpel blade, and suture, so preventing a CVC-related infection means keeping four restart needles out of the workplace.
- Bard IC Foley Catheter; this antimicrobial Foley catheter is a primaryprevention of sharps injury product because has been demonstrated to reduce catheter-associated urinary tract infections (CAUTIs), the most common nosocomial infection in the world. CAUTIs also predispose patients to urosepsis. Think of all the hollow-bore, blood-filled needles involved in a sepsis workup and treatment; infection control really does mean primary prevention.
- Duragesic® (Janssen Pharmaceutica Products) for needlefree drug delivery of (fentanyl transdermal system) CII for pain management.
- Surgical glues, such as Dermabond from Ethicon for needlefree wound closures
- Bilicheck (SpectRx), a non-invasive Bilirubin analyzer accurately measures the total serum bilirubin in neonatal patients.
The secondary sharps injury prevention products implemented by Florida Hospital include:
- B. Braun Introcan Safety IV catheters; these are safety IV catheters that offer a passive safety mechanism that is virtually impossible to circumvent. In studies at Mt. Sinai Hospital in New York, this safety catheter out-performed other leading active safety catheters. The hospital also uses the BD Insyte Autoguard safety IV catheter.
- Safety Introducers for PICCs; introducer needles are high-risk, so ensuring that these have engineered sharps protection is important.
- Monoject, Magellan safety syringes; clinicians should recall that a prestigious New York City hospital received a citation from the Occupational Safety and Health Administration (OSHA) for not using safety syringes.
- Mylar coated capillary tubes
- Safety phlebotomy systems from Sims Portex, Kendal and BD
- Galt safety scalpels
- Safety disposal systems from Kendall
The Florida Hospital System
In 1999, The Wall Street Journal named Florida Hospital the hospital of the future. The Florida hospital system now includes seven hospitals and 14 walk-in medical centers, servicing more than a million patients per year. The system is the Adventist Health Systems flagship organization and is consistently recognized for its superiority in heart, obstetrics, orthopedics, womens health, research, family practice, and cancer treatment.
Florida Hospital is continually updating our devices and protocols to reduce the number of stick injuries to both our employees and patients, states Karen Marcarelli, vice president of nursing. These include using needleless devices and the latest technologies in sutures designed to reduce the risk of infection. We are proud that our efforts in this important area of patient safety is being recognized with this award.
NAPPSI Launches Campaign for Primary Prevention of Sharps Injury
The National Alliance for the Primary Prevention of Sharps Injuries (NAPPSI) has launched a major campaign for a notification to clinicians on sharps injury prevention, to alert clinicians to the benefits of primary prevention of sharps injuries. The campaign focuses on petitioning health agencies in the United States to highlight the distinct benefits of primary and secondary prevention of sharps injuries.
The notification states: Healthcare workers who use or may be exposed to needles are at increased risk of needlestick injury. Such injuries can lead to serious or fatal infections with bloodborne pathogens such as hepatitis B virus, hepatitis C virus, or human immunodeficiency virus (HIV). In order to prevent bloodborne pathogens exposure, clinicians are advised to utilize both primary and secondary sharps injury prevention techniques. Primary prevention techniques eliminate the needs to introduce sharps into the workplace, thereby reducing the total number of sharps used. Secondary prevention techniques render safer those sharps that must be introduced into the workplace. The combination of primary and secondary prevention maximizes healthcare worker safety with respect to blood borne pathogens exposure from sharps injury. For more information, visit www.nappsi.org
Meet the 2005 NAPPSI/ICT Primary
Sharps Safety Award Sponsors
B. Braun is dedicated to providing innovative products that help deliver safer patient care, enhance performance and support best practices and compliance. The passive Introcan Safety® IV Catheter is designed to minimize accidental needlesticks without requiring user activation. Using the same passive technology, our Surecan® Safety Huber Needle is designed to protect against accidental rebound needlestick injuries for safe port access. The ULTRASITE® Needle-Free IV System, with positive displacement design, minimizes catheter occlusions while protecting patients and caregivers from accidental needlesticks.
Hospira is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness by developing, manufacturing and marketing products that help improve the safety and efficacy of patient care. Created from the core global hospital products business of Abbott Laboratories, Hospira is a new company with 70 years of service to the hospital industry. The companys portfolio includes the industrys broadest line of acute-care injectables and integrated solutions for medication management and infusion therapy.
Tyco Kendall has demonstrated its commitment to providing top-quality sharps containers, needles and syringes and blood collection products to the healthcare industry, developing and manufacturing the broadest range of products available withy the clinician in mind and strict quality control measures in place. The best products for the job, the safest products on the market.
BD (Becton Dickinson and Company)
Manufacturer of the BD Vacutainer® and Microtainer® brand and system of products, BD (Becton Dickinson and Company) is committed to identifying and helping to prevent sources of pre-analytical error through a combined product and service offering. Products include: BD Vacutainer® Push Button Blood Collection Set, BD Vacutainer® Eclipse Blood Collection Needle with Pre-Attached Holder, BD Vacutainer® Blood Transfer Device, BD Vacutainer® Blood Collection Tubes, BD Vacutainer® Latex Free Stretch Tourniquet.
StatLock safety securement devices replace the outmoded catheter fixation techniques of tape and suture to provide dramatically improved patient safety, healthcare worker protection and cost-benefits. StatLock is fast-becoming the new standard for securement of all medical tubes and catheters. In fact, the CDC has recently acknowledged that StatLock is superior to suture in reducing catheter-related blood stream infection. Similarly, OSHA and the U.S. Congress have recognized StatLock as a needlestick safety device under the law. StatLock the new standard of care for vascular access device securement.